Michael O. Idowu

Virginia Commonwealth University — United States

Medicine · Health Sciences

40h-index4.7kcitations203works3.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Liver Disease Diagnosis and Treatment(28), Cancer Immunotherapy and Biomarkers(17), Breast Cancer Treatment Studies(15), Cancer Cells and Metastasis(15), Liver Diseases and Immunity(12)

Publications203 total

Hepatic cells-induced immune responses exhibit anti-tumor function through non-cytotoxic liver homeostasis pathways 2981
The Journal of Immunology·2025Open Access
TATA-box binding protein-associated factor 2 (TAF2) in hepatocyte survival and tumorigenesis
Hepatology·2025· 1 citedOpen Access
Anti‐Tumour Immunity Relies on Targeting Tissue Homeostasis Through Monocyte‐Driven Responses Rather Than Direct Tumour Cytotoxicity
Liver International·2025· 4 citedOpen Access
Abstract 3336: Early detection of tumor relapse, racial disparity, and treatment resistance in triple negative breast cancer
Cancer Research·2025
T-cell immune checkpoint inhibition plus hypomethylation for locally advanced HER2-negative breast cancer: a phase 2 neoadjuvant window trial of decitabine and pembrolizumab followed by standard neoadjuvant chemotherapy
Journal for ImmunoTherapy of Cancer·2025· 9 citedOpen Access
Robotic Surgery in Africa: History, Contemporary, and Thereafter.
PubMed·2024Open Access
Utility of AI digital pathology as an aid for pathologists scoring fibrosis in MASH
Journal of Hepatology·2024· 15 citedOpen Access
Evidence of Novel Susceptibility Variants for Prostate Cancer and a Multiancestry Polygenic Risk Score Associated with Aggressive Disease in Men of African Ancestry
UNC Libraries·2024Open Access
Anti-tumor immunity relies on targeting tissue homeostasis through monocyte-driven responses rather than direct tumor cytotoxicity
2024· 2 citedOpen Access
Abstract PO1-18-04: Neoadjuvant pembrolizumab + decitabine followed by standard neoadjuvant chemotherapy for locally advanced HER2- breast cancer (NCT02957968)
Cancer Research·2024· 3 cited
Abstract 7664: Early detection of racial disparity and treatment resistance in triple negative breast cancer
Cancer Research·2024
Abstract C027: Persistent activation of this tumor-driving EGFR/RAS/RAF/MEK/MAPK/SIAH Pathway is highly prognostic in patient risk stratification, cancer disparity detection, and resistant/relapse/survival prediction at the 1st-line neoadjuvant settings
Cancer Epidemiology Biomarkers & Prevention·2023
Metastatic Uterine Leiomyosarcoma presenting as small bowel intussusception at two independent visits
Gynecologic Oncology Reports·2023· 3 citedOpen Access
The crosstalking immune cells network creates a collective function beyond the function of each cellular constituent during the progression of hepatocellular carcinoma
Scientific Reports·2023· 13 citedOpen Access
Restoration of CD4+ T helper cells without modulating the hepatic inflammatory pattern is not sufficient to prevent HCC
The Journal of Immunology·2023Open Access
Abstract 5531: Early detection of cancer disparity and treatment resistance in TNBC
Cancer Research·2023· 2 cited
Supplementary Figures from Exploitation of Sulfated Glycosaminoglycan Status for Precision Medicine of Triplatin in Triple-Negative Breast Cancer
2023Open Access
Data from Exploitation of Sulfated Glycosaminoglycan Status for Precision Medicine of Triplatin in Triple-Negative Breast Cancer
2023Open Access
Supplementary Figure 3 from A Human Breast Cell Model of Preinvasive to Invasive Transition
2023Open Access
Supplementary Figure 5 from A Human Breast Cell Model of Preinvasive to Invasive Transition
2023Open Access
page 1 of 11Next →

Frequent Co-authors

Arun J. Sanyal(11), Mohammad Shadab Siddiqui(8), Prem Puri(7), Masoud H. Manjili(7), Raouf E. Nakhleh(7), Velimir A. Luketic(6), Melissa J. Contos(6), Richard K. Sterling(5), Xiang‐Yang Wang(5), Harry D. Bear(5), Rhona J. Souers(5), Faridoddin Mirshahi(4), Sherry Boyett(4), Catherine I. Dumur(4), Celeste N. Powers(4), Scott Matherly(4), Kyle K. Payne(4), Richard T. Stravitz(3), Chandra Bhati(3), Carolyn Driscoll(3)